title: Prolonged treatment with the atypical antipsychotic agent remoxipride reduces extracellular glutamate levels in the striatum of freely moving rats.
authors.affiliation: Department of Pharmacology, Astra Arcus AB, Södertälje, Sweden.
authors.forename: O
authors.initials: O
authors.lastname: Magnusson
authors.forename: G
authors.initials: G
authors.lastname: Serrano-Lundkvist
authors.forename: I
authors.initials: I
authors.lastname: Henriksson
authors.forename: B
authors.initials: B
authors.lastname: Mohringe
authors.forename: S O
authors.initials: SO
authors.lastname: Ogren
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D003956:Dialysis; D018698:Glutamic Acid / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D017330:Remoxipride / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D014150:Antipsychotic Agents; D017330:Remoxipride; D018698:Glutamic Acid